Patients with a high estimated fraction (>90th percentile) of either tumor-infiltrating CD8+ T cells or plasmalemma vesicle associated protein (PLVAP)+ endothelial cells were separately present in the scatter plot, suggesting mutual exclusivity of the two cell types concerning clinical outcome in the ccRCC environment. Here, CD8A is linked to nonpapillary renal cell carcinoma.